Howard Berman - Jan 31, 2024 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Chief Executive Officer, Director
Signature
/s/ David Snyder, Attorney-in-Fact
Stock symbol
COYA
Transactions as of
Jan 31, 2024
Transactions value $
$0
Form type
4
Date filed
2/2/2024, 08:00 PM
Previous filing
Mar 1, 2023
Next filing
Jun 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Award $0 +190K $0.00 190K Jan 31, 2024 Common Stock, par value $0.0001 per share 190K $5.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date.